The purpose of this study was to investigate if rapidly measured physical properties can predict glassforming ability and glass stability of drug compounds. A series of 50 structurally diverse drug molecules were studied with respect to glass-forming ability and, for glass-formers (n = 24), the physical stability upon 1 month of storage was determined. Spray-drying and melt-cooling were used to produce the amorphous material and the solid state was analysed by Differential Scanning Calorimetry (DSC) and Powder X-ray Diffraction. Thermal properties and molecular weight (Mw) were used to develop predictive models of (i) glass-forming abil ity and (ii) physical stability. In total, the glass-forming ability was correctly predicted for 90% of the drugs from their Mw alone. As a rule of thumb, drugs with Mw greater than 300 g/mole are expected to be transformed to its amorphous state by using standa rd process technology. Glass transition temperat ure and Mw predicted the physical stability upon storage corr ectly for 78% of the glass-formin g compounds. A strong sigmoidal relationship (R 2 of 0.96) was identified between crystallization temperature and stability. These findings have the potential to rationalize decisions schemes for utili zing and developing amorphous formulations, through early predictions of glass-forming ability from Mw and physical stability from simple DSC characterization.
When developing a dosage form for an active compound with poor solubility, preformulation data give rather unspecific information on what formulation strategies to apply (Branchu et al., 2007; Kawabata et al., 2011 ) . A higher degree of predictio n and precision in decision making would enable more efficient drug product development and provide an early stage insight into the potential of solubility limited drug compounds to be processed into functional and stable dosage forms. In this context, it is necessary to develop methods that can predict the solid state behaviour of drug compounds during processing and manufactur ing. Solid state alterations, in particular amorphization , often have significant influence on the performance of a substance, impacting for instance mechanical properties (Ziffels and Steckel, 2010 ) , dissolution (Lindfors et al., 2006; Murdand e et al., 2010 ) and bioavailabili ty (Hancock and Parks, 2000 ) . Amorphization is hence a strategy with high potential to increase bioavaila bility of compounds for which poor solubility is limiting intestinal absorption. However, as the inherent instability of the amorphous state limits production, handling and use of products based on amorpho us compounds , research efforts are currently directed towards methods that stabilize the amorphous phase (Kearns et al., 2008; Laitinen et al., in press ) . Fundamental aspects governing the physical stability, i.e. the resistance of an amorphous compound to be transformed into its crystalline state, has lately been in focus with the purpose to obtain an increased understa nding of the dynamics (Aso et al., 2001; Bhattacharya and Suryanar ayanan, 2009; Singh and de Pablo, 2011; Stukalin et al., 2009 ) and nucleation processes (Marsac et al., 2006; Vyazovki n and Dranca, 2007 ) .
Thermodynam ically the physical stability is governed by the differenc e in Gibbs free energy between the amorphous and the crystalline states. Both nucleation rate and crystal growth is however also affected by the dynamics, i.e. the molecular mobility, of the amorpho us phase. The glass transition temperature (T g ) has therefore been used as a reference temperature when determining glass-for mation temperature s (Corrigan et al., 2004; Yamaguchi et al., 1992 ) and storage temperature s (Hancock et al., 1995; Schoug et al., 2009 ). However, the predictive capacity of T g for physical stability has been shown to be poor, which is manifested, by for instance, the observati on that compounds with similar T g may have different amorphous stability (Marsac et al., 2006 ) , and that alteration s in amorphous stability attained by variations in production settings not always are reflected in observable changes of T g (Yamaguchi et al., 1992; Zhang et al., 2009 ) . Some recent publications have described the use of statistical methodology to find other physicochem ical propertie s that correlate with glass-forming ability and glass stability. In these, the interest has been to predict and understand which compounds can be made stable amorphous based on the thermodyna mic and kinetic properties of the compounds. Greaser et al. made univariat e correlation analysis of kinetic and thermod ynamic paramete rs to assess storage stability of nine drug compounds and found configurational entropy to be the parameter that best described the stability (Graeser et al., 2009 ) . In another study, logistic regression analysis was used to find that T g and molecular volume combined predict glass-forming ability for a number of compounds when exposed to mechanical treatment (milling) (Lin et al., 2009 ). Taylor and co-worke rs have analysed a larger dataset of compounds (n = 51) by principal component analysis (PCA) and found that molecular properties (number of rotational bonds and molecular weight) are important, but also that thermal properties (heat of fusion, entropy of fusion, the free energy differenc e between the crystalline and amorphous states and melting temperat ure) need to be included to separate glass-for mers from poor glass-forming compounds . The same factors were found to be important for discriminati ng fast, intermedi ate and slow crystallizers in a follow up study on physical stability of amorpho us drugs . Although these attempts have identified some properties that likely will influence the stability of the amorpho us material, no conclusions have been reached on the understanding of the fundamenta l propertie s governing amorphous phase formation and stability of drug like compounds .
Recently we have shown how statistical modelling by partial least squares projection to latent structure s discrimin ant analysis (PLS-DA) can be used to predict glass-forming ability of compounds from their molecular structure (Mahlin et al., 2011 ) . The establishment of a model that used molecular descriptors reflecting size, branching, distribution of electronega tive atoms, symmetry and number of benzene rings correctly predicted 75% of the compounds in an external test set. In the present work, we continued to explore the inherent ability of pure drugs to form an amorphous state in settings comparable to standard production conditions. A series of 50 structurally diverse drugs was investigated upon processing by spray-drying and melt-cooling. For the compounds thereby showing good glass-forming ability we further studied the inherent ability to remain in the amorpho us state upon storage. This resulted in two datasets; a dataset for the ability to form the glass, in which the compounds were sorted as (i) glassformer or (ii) nonglass -former, and a dataset for the stability of the formed material, in which the compound s (n = 24) were classed as (iii) stable glass or (iv) non-stable glass. The datasets were used together with experimental ly measured physical properties to develop models predicting glass-forming ability and glass stability, applicable as preformulation tools in early drug developmen t.
Methods

Materials
In this study, a dataset previously investiga ted for glass-forming ability (Mahlin et al., 2011 ) , and for which most of the compounds display solid-state limited aqueous solubility, was extended with a diverse set of molecule s to allow general conclusions to be drawn applicable to the drug-like space of oral drugs. In total 50 compounds were included in the final dataset subjected to analysis of properties of importance for glass-forming ability and glass stability (Table 1 ). All of the compound s studied were used in their free form, i.e. no salts of compounds were included. Differential Scanning Calorimetry (DSC) verified that the starting material was crystalline and none of the compounds showed any traces of solvates. Bicalutam ide, felodipine and linaprazan were received as a kind gift from AstraZeneca (Mölndal, Sweden) and acitretin was purchased from Ontario Chemicals (Canada). All the other drugs were obtained from Sigma-Aldrich Chemie GmbH (Germany). The specified purity of the drugs used was >98%, except for griseofulvin (>96%). Ethanol (Alita Corporat ion, Finland) and acetone (VWR Internationa l S.A.S., France) were used as solvents in the spray-drying feed solution.
Production and identification of the amorphous form
Two different methods , spray-drying and melt-cooling, were used to test the susceptibility of the compounds to be transformed into the amorphous form. Only the compounds for which both these methods resulted in the same outcome, i.e. formatio n of either a crystalline or an amorphous solid, were included in the dataset that was utilized for statistical modelling. The dual production procedure was applied for two reasons. Firstly, the idea was to identify the inherent glass-forming ability of the drug compound s rather than the process depende nt glass-forming properties. Secondly, we wanted to minimize the risk of false classification that may be caused by hidden processes that affect the outcome, such as chemical degradation upon heating. Melt-cool ing was done in DSC using unprocessed substance and spray-dryi ng by using solutions of the compounds as described in detail previously (Mahlin et al., 2011 ) . Briefly, the solubility of each compound in a solvent mixture of ethanol and acetone (90:10 w/w) was determined by preparin g a dispersion of the drug in the solvent mixture, which was subsequently stepwise diluted and sonicated until complete dissolution was observed. Solutions of the compounds at a concentration correspondi ng to 75% of the solubility were spray-dried in a Büchi B-290-Mini Spray Dryer with an inert loop (Büchi Laboratoriums, Switzerland) using a standardise d procedure with the following settings: inlet temperature 50°C, pump rate of spray solution 4 ml/min, and aspirator rate 75% of the maximum flow. The produced material was dried over vacuum at room temperature (22°C) for 1 h prior to solid state analysis.
The solid state of the spray-dried material was analysed by DSC (DSC6200, Seiko, Japan). The temperature and heat flow was calibrated using indium. Approxim ately 2 mg of each compound were weighed into aluminium pans (TA Instrument standard pan, Waters, UK) with perforated lids and analysed using a heating rate of 20°C/min enabling full separation of crystallizati on and melting peaks. The analysis was run from 20°C to a temperature above the melting point of the compound (T m ) while being purged with nitrogen gas (80 ml/min). No signs of residual solvents desorbing during heating was observed in the DSC signal. The presence of amorphous phase in the samples was judged from the occurrence of glass transition and exotherm ic crystallization peaks in the heat flow signal upon heating, alternativel y a complete absence of crystallization and melting peaks. The glass transition was determined from the mid-point of the step change in heat flow and the amorphous content of the spray-dried compounds was estimated from:
where DH cr is the enthalpy of crystalliza tion and calculated from area under the crystalliza tion peak in the thermogr am, and DH is the difference in enthalpy between the amorphous and crystalline state at the crystalliza tion temperatu re (T cr ), and given by
where DH m is the melting enthalpy, T m the melting temperatur e and
where C am p and C cr p are the heat capacities of the amorp hous and crystalline state, respective ly. As an approximat ion, DC p can be assumed to be constan t and calculate d according to Thompson and Spaepen (1979) :
where DH m and T m is obtained from the DSC data.
The solid state of the spray-dried material was further verified by X-ray Powder Diffraction analysis. Diffraction patterns were obtained by using a Kratzky camera with a linear position-sen sitive wide angle detector (HECUS M. BRAUN X-ray Systems, Graz, Austria) detecting diffracted radiation in a 2h interval from 17°to 25°(given by the limits of the detector) in steps of 0.01 °. The radiation was generated by an Cu Ka X-ray generator (Philips, PW 1830/40) working at 40 V and 50 A. The temperature was controlled to 25°C by a Peltier element. Each sample was run for 15 min in vacuum. When the X-ray analysis showed a diffuse scattering pattern the sample was considered to be predominantly amorpho us, while samples generating diffraction patterns with distinctiv e peaks were considered to contain crystalline phase. Table 1 Physicochemical and glass stability characteri stics of the compounds studied. The ability of the compound s to become amorphous when cooled from the pure liquid state was investiga ted by cooling melts of the drugs in the DSC. The experimental conditions were the same as for the analysis of spray-dried material, except that approximat ely 2 mg of unprocessed substance was weighed into the aluminium pans. The samples were analysed by performing two heating/coolin g cycles, the first for melt-cooling and the second for analysis. During the first cycle the samples were heated from room temperat ure to approximately 10°C above their T m at a heating rate of 20°C/min and immediatel y cooled at a rate of 40°C/min. To analyse the presence of an amorphous phase after the first cycle, the second DSC cycle was performed in the same way as the DSC run to determine the amorphous content of the spray-dried material. No thermal events other than the expected glass transitions, crystallizations and melting, were observed in the DSC signal upon heating of the material.
Dry stability of amorphous material
The spray-dried material of the pure drug compound was put on short term storage to provide an indication of the dry stability of the glass-formers when kept in the glassy state, below their T g . Therefore, all compounds being partially or completely amorphous after spray-dryi ng were stored for 1 month in glass vials over silica gel in an evacuated desiccator at room temperature (22°C). The solid state of each compound was then analysed again by DSC applying the same DSC protocol as used immediately after production. The fraction of the amorphous phase that had been transformed into a crystalline state upon 1 month of storage (a) was calculated by
where DH stored cr is the heat of crystalliza tion of the solid after storage and DH cr the same as above, i.e. heat of crystalliza tion determine d immediat ely after spray-dry ing.
Analyses of glass-forming ability and dry stability -relation to physical properties
The glass-forming ability and dry stability were analysed for their depende nce of the following measured physical properties which were obtained from DSC analysis of the unprocessed crystalline material: T m (onset of melting peak), DH m (melt enthalpy from melting peak area), DS m (entropy of melting) and DG cr (Gibbs free energy of crystallization at storage temperature), and analysis of amorphous material obtained after spray-drying: T g (the midpoint of the glass transition temperat ure) and T cr (onset of crystallization temperature upon heating at 20°C/min). In addition, Mw, which previously has been identified as an important molecular property for glass-forming ability and the following adjusted properties were included: reduced T g (T g,red which is equal to the ratio
T cr /Mw, DG cr Â T cr and DG c /T cr . These adjusted parameters were introduced to make possible the finding of relations between parameters that are non-linea rly interdependen t. An estimated value of T g was calculated for compounds for which T g could not be determined from the thermal analysis, using a procedure described by Baird et al. (2010) . In short, the T g,red of the compound s for which T g had been experime ntally determined was plotted as a function of Mw. A straight line was fitted to the plot and thereby a theoretical T g could be calculated from the obtained straight line equation.
All the above described properties were included as variables and subjected to PLS-DA as implemented in Simca v.11 (Umetrics, Sweden). The following procedure was used to develop the classification model of glass-forming ability: The computational model for glass-forming ability (n = 50) was designed to different iate between glass-for mers, i.e. compounds able to form an amorphous state from both spray-drying and melt-cooling (assigned value 1), and non-glass-for mers, i.e. compound s remaining crystalline irrespect ive of production technology used (assigned value À1). This classification neither took into account how much of the material that had become amorphous upon processin g nor whether the amorphous material was stable over time; only the ability to exist in the amorphous state after being subjected to the two material processing techniques was modelled. It should here be noted that the melt-quenchi ng and spray-dryi ng are two fundamentally different routes for solid formation, the former a transformation from the melted state and the latter from a solution. This should certify that we are studying the inherent glass-forming propensi ty of the drugs. The dataset was divided into training (2/3) and test (1/3) sets to allow assessme nt of general applicabi lity of the models developed. Standard settings in Simca, including seven cross validation groups, were used.
The model for glass stability was devised to separate stable glasses, defined as compounds which had retained more than 50% of the amorpho us content after 1 month of storage (assigned the value 1), from non-stabl e glasses defined as compounds that lost more than 50% of the amorpho us content during this time period (assigned value À1). Albendazole was excluded from the stability modelling due to its high crystalline content after production (82%) which possibly could obscure a correct analysis of the stability of the amorphous phase and hence increasing the risk of false classification, Due to the small number of compound s (n = 23) and that the number of compound s in the stable group (n = 15) was large compared to the unstable group (n = 8), all the compounds were included in the model developmen t. To give the two groups equal weight, the unstable group was duplicated in the input matrix used for PLS-DA, resulting in that informat ion from the same compound was repeated eight rows down in the matrix. This approach has been identified as suitable when modellin g significantly different group sizes. In the model developmen t of dry stability the number of cross validation groups was set to eight in order to simultaneously leave both duplicates out in the cross-validati on of the model.
In the model developmen t for both glass-forming ability and stability, the data were mean centered and scaled to unit variance, and variables that were skewed were excluded from the model developmen t to not distort the models. The models were developed using the following schedule to allow as much information to be extracted as possible: (i) only thermodynam ic propertie s (T m , DH m , DS m , DG cr ) were used as input variables (n = 4), (ii) to matrix i, T g related properties were added (n = 11) and (iii) to matrix ii, Mw related properties were added (n = 20). In the modelling of glass stability matrix iv was created by adding T cr related properties were to matrix iii (n = 29). From each starting point (i-iv) a variable selection was performed in which input information that was not directly related to the response (i.e., noise) was removed, and thereby the predictivity and robustness of the model was increased. The accuracy of the statistically significant PLS-DA models was judged by how well the two classes of the training sets were separated from each other. In addition, for glass-forming ability, once the selection of physical propertie s had been finalized the resulting models were validated with the test set.
To evaluate the models for glass stability, the fraction of the amorpho us phase that had been transformed into a crystalline state upon 1 month of storage (a) was plotted against T g , Mw, T cr and the prediction values obtained from the PLS-DA model based on T g and Mw. A sigmoidal relationship
was fitted to the data points in the plots by adjustment of the shape factors T 0 and k.
Results and discussion
Preparation of amorpho us materials -glass-formi ng ability
The results from the classification of glass-forming ability of the 50 compounds are presented in Table 1 . For all compounds there was an agreement between DSC and X-ray data, as a clear crystallization peak visible in the thermogram upon heating in all cases coincided with a diffuse background scattering without diffraction peaks in X-ray. In the case of glibencla mide, metolazone and warfarine, the absence of both a crystallization peak and a melting peak in the DSC thermogr am was taken as the sample being amorphous and stable upon heating. The X-ray analysis of these compounds confirmed they being predominantly amorphous state. Albendazole and Nifedipine showed small crystallization peaks and estimations based on the DSC-data showed that were just partially amorphous (approximately 18% and 67%, respectivel y). Of the 50 compounds investigated , 26 were detected to be crystalline (no amorphous phase detected) after both melt-cooling and spray-drying whereas 24 showed partly or complete transformat ion to the amorphous form. Hence, the latter 24 were classified as glassformers (see Table 1 ).
Stability of dry amorphous material
After storage for 1 month, DSC-anal ysis showed that 15 of the glass-forme rs had preserved more than 50% of its amorphous content (see Table 1 ). For 13 of these, the fraction crystallized was <5% which is within the uncertainty of the crystallinity determination by this method. Bicalutamide and omepraz ole lost approximat ely 11% and 36% of their amorphous content, respectively . For the compounds classified as unstable, no amorpho us phase could be detected by DSC after storage, except for griseofulvin, felodipine and acemetacin, which according to our calculations had a crystallinity of 95%, 79% and 56%, respectively, after storage.
Physical properties of importanc e for glass-formi ng ability of drugs
In order to find out if thermodyna mic properties could be used for predictio ns of glass-forming ability a PLS-DA was performed based on the thermodynam ic quantities T m , DH m , DS m and DG cr . These are easily measured by using a crystalline sample of a compound using standard DSC equipme nt. However, the PLS-DA modelling attempts resulted in non-significant models (data not shown). In the next step, we therefore also included T g -related parameters, which are assumed to represent properties related to the molecular mobility of the amorphous state. Interestingl y, the most predictiv e model, shown in Fig. 1 , did not include any parameter representing an absolute temperature paramete r (T m or T g ), as could be expected since the quality of the amorpho us product formed often are related to differenc e between formation temperature and T g (Yamaguchi et al., 1992 ) . Instead it was the balance between thermodyna mic and kinetic properties, i.e. the adjusted parameters involving both T m and T g , that carried most information. In this case, the predictivity was 81% for the test set (Fig. 1A) . The model was based on T g,red , T m À T g , DS m , DG cr Â T g,red , DH m , DG cr /T g,red and DG cr /T g,red and hence, the analysis showed that the T g -related properties indeed carry informat ion of importance for the prediction of glass-for ming ability.
In a general context, larger molecules are commonly less prone to crystallize from a liquid state . Therefore, we wanted to evaluate the effect of Mw on the predictio ns and hence, a new model was built including all former paramete rs, together with Mw-related properties. In this analysis, only the adjusted paramete r T g,red Â Mw remained after model refinement and this property predicted 91% and 94% correctly of the training and test sets, respectivel y (Fig. 1B) . We also found that equal predictivity was obtained from Mw alone (accuracy of training and test sets of 88% and 94%, respectively , Fig. 1C) . The results obtained herein, based on a large and structurally diverse drug-like dataset, strengthen previous findings of the importance of molecula r size and T g as predictors of glass-forming ability (Lin et al., 2009 ). In the scientific discussion, it is often referred to Kauzman n (1948) and Turnbull (1969) who suggested that compounds with a T g,red higher than 2/3 are good glass-formers. The theoretical rationale for this effect is that compound s with smaller super-cooled liquid regime (i.e. high T g,red ) have a lower probability for nucleation when cooled below its melting temperature due to less time spent in that critical region. This has been confirmed in a study on a homologous series of cyclic stilbenes (Ping et al., 2011 ) , but in the same publication it was argued not to be true when looking at more diverse chemical structures. Recently it was shown by Baird et al., that for a set of drug compound s the T g,red is not useful for predictin g glass-for ming ability . This is partially in line with our observation that Mw is a good predictor by itself, and that the T g,red contributes with minor information . This was further underlined by that T g,red alone was a poor predictor (data not shown). We therefore propose that for compounds with a molecula r weight range corresponding to common poorly soluble drugs, propertie s relating to molecular size is the dominating factor determining glass-forming ability, whereas for limited series of compound s with similar molecular weight, the T g,red may be more useful for predictions. Some publications highlight the role of the configurational entropy differenc e between the amorpho us and crystalline state, and that compounds with higher Mw have more complex molecular structure and hence, are less likely to exist in an ordered crystalline state Graeser et al., 2009; Zhou et al., 2002 ) . Therefore, there seems to be a rational behind using the Mw as an easily obtained surrogate for description of configurational entropy, although the latter property also is depende nt on other structural features, e.g. number of rotatable bonds. Further, it has been suggested that the complexity associate d with larger molecules means that it has to probe a larger number of possible conformations and configurations to find an ordered (crystalline) packing structure during solidification . It is appealing to imagine the tendency of becoming either amorpho us or crystalline as being dependent on the molecula r process of probing the various possible conformations and configurations (related the configurational space, and hence to the Mw of the compound) and the time available to find a configuration that will produce an ordered crystal unit during solidification (related to the T g,red at constant cooling conditions).
In the present study, the dominating factor for glass-formatio n seems to be Mw. In Fig. 2 the relation between Mw and glass-forming ability is visualized. From our analysis, based on a large structurally diverse dataset we suggest that compounds with Mw above 300 g/mole are likely to be transformed to the correspondi ng glass using standard production/am orphization technolo gies, whereas compounds with Mw below this value will be difficult to produce amorpho us. It should be kept in mind that we base this conclusion on compound s having a melting point higher than 140 °C. However, the general applicabi lity of this rule-of-thumb was confirmed by applying the analysis on the 51 compounds studied by Baird Fig. 1 . Accuracy of the prediction of the glass-forming ability for the training set and the test set used. Training set used for model development is shown as open squares, test set as filled circles. Glass-formers were given the value 1 and nonglass-formers (i.e. compounds remaining crystalline after being processed by both spray-drying and meltcooling) were given the value À1. Observed glass forming ability is shown on the y-axis, predicted on the x-axis. (2010) . For this dataset, 84% of the compounds were correctly sorted with regard to their glass-forming ability when using Mw of 300 g/mole as the cut-off value.
Physical properties of importance for dry stability of amorphous drugs
In the same way as for glass-forming ability, the glass stability was analysed step-wis e. The thermodyna mic properties did, again, not result in a significant model for dry stability. The variable selection after including the T g -related propertie s to the model developmen t resulted in that T g was found to be the single most important property , and did by itself predict 65% of the compounds accurately (Fig. 3A) . After inclusion of Mw the final properties remaining after the variable selection were T g and Mw and the predictivity increased to 78% (Fig. 3B) . It should be noted that all T g -values except one (bezafibrate) used in stability modelling have been experimental ly determined.
Since no test set was available for validation, the stability model developed was evaluated using the calculated fraction of the amorphous phase transformed during storage (a). A plot of a as a function of the prediction values generate d by the model is displayed in Fig. 4 . This shows the model is not only able to separate the two classes stable and non-stabl e with 78% certainty, but also able to assign the lowest values (<À0.5) for all the compounds that was fully crystallized upon storage, and highest values (>0) for all the compound that did not crystallize during storage (the only exception being griseofulvi n having high predictio n value but low stability). There seem to be a sigmoidal relation between the predicted values and a which further support the validity of the model. The rational for why a model based on the paramete rs T g and Mw is able to predict glass stability can be deducted in a similar way as for glass-forming ability, i.e. it is the balance between the molecular mobility (the rate of molecula r motion) and the configurational space (how many configurations that can be probed) that governs crystallization tendency of a compound. It has been shown that molecula r mobility determines the rate of crystallization of an amorphous phase when analysing the temperature dependency of single amorpho us compounds (Aso et al., 2001; Bhattachary a and Suryanarayanan, 2009; . However, when it comes to comparing crystallization tendencies for a number of structura lly diverse compounds other factors has to be considered to predict physical stability and one factor identified to be important is the configurational entropy (Graeser et al., 2009; Zhou et al., 2002) . Based on this we hypothesize that T g and Mw is describin g molecula r mobility and configurational entropy well enough to, when combined, be able to predict glass stability. It is interesting to note that the compound being poorest predicted by the Mw-T g -storage model, griseofulvi n, has been extensively studied as to find out the reason for its sensitivity to production conditions, since its stability is higher when amorphisized by melt-cooling as compare d to milling (34-36).
Crystallizatio n temperature
A glass heated above its T g may crystallize before it reach the thermod ynamic melting temperature . The onset of this crystallization is dependent on the nucleation tendency and crystal growth rate of the heated amorphous system Hancock and Zograf, 1997 ) . At a well-defined heating rate and sample size, the onset temperature of crystallization (T cr ) can be regarded as an indicator of the crystallization tendency of the amorpho us compound. However, no evaluation of the capacity of T cr to predict storage stability for a number of relatively diverse drug compound s has so far been published. Since we in this study had information on physical stability of the amorphous phase upon storage below T g we had an opportunity to study is relation to T cr . Hence, T cr was included as an input paramete r and evaluated by the PLS-DA modelling. In the refined model T cr remained as the only parameter, on its own giving the best predictivity, with 95% accurate classification of the compounds (Fig. 3C) . To further evaluate this correlation a plot of a as a function of the T cr was done. As for the stability prediction model a strong sigmoidal relationship (R 2 of 0.96 upon fitting to Eq. (6)) was obtained (see Fig. 4 ). No clear outliers from this relation were found, indicative of that T cr is able to capture the important factors that govern the physical stability of amorpho us compounds upon storage below T g . Although the relation between molecular mobility and crystallization of amorphous compounds below and above T g has been studied previously Caron et al., 2010 ) , such a clear and simple correlation between T cr and storage stability as the one observed here has, to the best of our knowledge, not been reported. T cr has shown to be sensitive to the condition of an amorphous material in terms of physical aging (Surana et al., 2004) and pre-nucleat ion (Trasi et al., 2010; Wu and Yu, 2006 ) which in turn is dependent on the production setting and thermal history of the amorpho us phase. Hence, it seems logical that T cr better describes the stability than Mw and T g , since the latter can be regarded more as intrinsic material properties. Therefore, it is very likely that the T cr better correlates to storage stability of amorphous materials produced by different technologies and at different conditions. However, further studies are needed to confirm this assumption. From a prediction perspecti ve, the 78% accuracy obtained using T g and Mw justify the usage of these properties to predict the inherent glass stability of compounds in the early part of the drug developmen t process, since T g may be estimated from calculatio ns or simulations (Xiang and Anderson, 2013 ) in silico . However, T cr may more accurately foresee stability later during the drug developmen t process, in particular during stages when decisions are to be made with regard to preferred production technology for the amorphizat ion.
From the plot in Fig. 4 , it is apparent that a compound with a T cr higher than 100 °C is stable upon 1 month of storage at 22°C. This relation can also be expressed as that an amorphous compound has to be stored at no less than 80°C below its T cr in order to be stable for 1 month, and is valid for T cr -values determined at a heating rate of 20°C/min. However, the validity for other storage temperatures, relative humidities and formulation s compositi ons must be further evaluated. Fig. 2 . Single correlation between glass-forming ability and molecular weight. Based on the results from the 50 compounds studied herein a cut-off for Mw of 300 is suggested for rapid prediction of glass-forming ability, with compounds having Mw > 300 mg/mole likely to be good glass-formers.
Conclusion
In this work we have studied a large series of structura lly diverse compound s and from thermal analysis and multivariate data analysis identified important properties to forecast the inherent drug properties glass-forming ability and dry stability of the produced amorphous material. The glass-forming ability was shown to be well predicted from Mw alone. The results suggest that as a rule-of-thumb , drugs with Mw greater than 300 g/mol are expected to be transformed to its amorpho us state using standard process technology. In addition, Mw together with T g predicted the dry stability of 78% of the amorpho us drugs correctly.
(A) (B) (C) Fig. 3 . Accuracy of the prediction of the glass stability for the training set used. Correctly predicted compounds are shown as black circles, falsely predicted in red. Compounds being stable amorphous were given the value 1, whereas unstable compounds were given the value À1, and all experimental data obtained in this study was used in the analysis of properties of importance for amorphous stability. Observed glass stability is shown on the y-axis, predicted on the x-axis. In this study we also identified a strong relationship between T cr and the dry stability of the amorphous drugs. In addition to inherent compound properties, T cr is sensitive to structural changes in an amorpho us phase of importance for its stability, thereby being more accurate for produced amorphous materials. Taken together the findings in this study show that early stage evaluations of the inherent glass-forming ability of a compound can be made from Mw. For glass-forme rs, Mw together with calculated or simulated T g can be used to predict the storage stability of the amorphous form of a drug. When an amorphous material has been produced we suggest that the T cr can be used to evaluate and rationalize the selection of production technology and optimal production settings. These properties, e.g. Mw, T g and T cr , have the potential to rationalize decision-ma king in drug developmen t as they help judging the potential of a compound to be formulated amorphous.
